FTAZX
Price
$9.87
Change
-$0.00 (-0.00%)
Updated
Jun 30 closing price
Net Assets
608.05M
MSVAX
Price
$10.35
Change
+$0.01 (+0.10%)
Updated
Jun 30 closing price
Net Assets
347.8M
Interact to see
Advertisement

FTAZX vs MSVAX

FTAZX vs MSVAX Comparison Chart in %
View a ticker or compare two or three
VS
FTAZX vs. MSVAX commentary
Jul 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTAZX is a Hold and MSVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTAZX has more cash in the bank: 608M vs. MSVAX (348M). FTAZX (3.37) and MSVAX (3.23) have matching dividends . FTAZX was incepted earlier than MSVAX: FTAZX (39 years) vs MSVAX (42 years). MSVAX (0.90) is less costly to investors than FTAZX (0.67). FTAZX is a more actively managed with annual turnover of: 17.42 vs. MSVAX (9.00). MSVAX initial investment is less costly to investors than FTAZX (4%) vs FTAZX (4%). FTAZX (1000) and MSVAX (1000) have matching initial minimum investment requirements. FTAZX annual gain was more profitable for investors over the last year : 7.67 vs. MSVAX (7.20). MSVAX return over 5 years is better than : 2.54 vs. FTAZX (0.74).
FTAZXMSVAXFTAZX / MSVAX
Total Expense Ratio0.670.8282%
Annual Report Gross Expense Ratio0.670.9074%
Fund Existence39 years42 years-
Gain YTD2.4852.129117%
Front Load4%4%88%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets608M348M175%
Annual Yield % from dividends3.373.23104%
Returns for 1 year7.677.20107%
Returns for 3 years12.3911.05112%
Returns for 5 years0.742.5429%
Returns for 10 years3.0114.3221%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFIPX30.79N/A
N/A
Franklin Global Equity A
ETIHX58.38N/A
N/A
Eventide Healthcare & Life Sciences I
TICIX45.14N/A
N/A
Timothy Plan Israel Common Values I
RYIMX24.66N/A
N/A
Guggenheim Multi-Hedge Strategies I
PIIDX17.44N/A
N/A
Principal International Equity R-6